Holen Sie sich die Stockscreener-App
10.00
2.44%
-0.25
Handel nachbörslich:
10.00
Schlusskurs vom Vortag:
$10.25
Offen:
$10.25
24-Stunden-Volumen:
39,915
Relative Volume:
0.64
Marktkapitalisierung:
$260.02M
Einnahmen:
$26.00M
Nettoeinkommen (Verlust:
$-219.71M
KGV:
-0.2008
EPS:
-49.8
Netto-Cashflow:
$-51.37M
1W Leistung:
-2.72%
1M Leistung:
-19.87%
6M Leistung:
-43.95%
1J Leistung:
-25.71%
1-Tages-Spanne:
$9.8466
$10.25
1-Wochen-Bereich:
$9.70
$10.48
52-Wochen-Spanne:
$8.46
$26.50
Cartesian Therapeutics Inc Stock (RNAC) Company Profile
Firmenname
Cartesian Therapeutics Inc
Sektor
Branche
Telefon
301-348-8698
Adresse
7495 NEW HORIZON WAY, FREDERICK
Vergleichen Sie RNAC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RNAC
Cartesian Therapeutics Inc
|
10.00 | 255.86M | 26.00M | -219.71M | -51.37M | -49.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Cartesian Therapeutics Inc Stock (RNAC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-09 | Eingeleitet | Wedbush | Outperform |
| 2024-12-19 | Eingeleitet | BTIG Research | Buy |
| 2024-08-06 | Eingeleitet | TD Cowen | Buy |
| 2024-07-02 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-06-04 | Eingeleitet | Oppenheimer | Outperform |
| 2024-05-24 | Eingeleitet | Mizuho | Buy |
| 2024-04-23 | Bestätigt | H.C. Wainwright | Buy |
| 2024-04-23 | Eingeleitet | Leerink Partners | Outperform |
| 2023-08-18 | Herabstufung | SVB Securities | Outperform → Market Perform |
| 2022-06-14 | Bestätigt | Needham | Buy |
| 2022-06-06 | Eingeleitet | SVB Leerink | Outperform |
| 2021-06-15 | Eingeleitet | BTIG Research | Buy |
| 2021-01-26 | Hochstufung | Mizuho | Neutral → Buy |
| 2020-10-01 | Herabstufung | Mizuho | Buy → Neutral |
| 2020-10-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2020-06-12 | Herabstufung | Stifel | Buy → Hold |
| 2020-04-28 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-01-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-01-21 | Eingeleitet | William Blair | Outperform |
| 2018-06-27 | Eingeleitet | Janney | Buy |
| 2017-03-30 | Bestätigt | UBS | Buy |
Alle ansehen
Cartesian Therapeutics Inc Aktie (RNAC) Neueste Nachrichten
Long term hold vs stop loss in Cartesian Therapeutics Inc.Quarterly Profit Review & AI Powered Market Entry Ideas - Newser
Will Cartesian Therapeutics Inc. continue its uptrendJuly 2025 Levels & Low Risk High Reward Trade Ideas - Newser
Cartesian Therapeutics Inc. stock volume spike explained2025 Performance Recap & Technical Pattern Alert System - Newser
Chart based exit strategy for Cartesian Therapeutics Inc.Weekly Trend Summary & Safe Entry Point Alerts - Newser
Published on: 2025-09-03 04:28:46 - Newser
How to build a dashboard for Cartesian Therapeutics Inc. stockFed Meeting & Capital Protection Trading Alerts - Newser
What Technical Tools Say About Cartesian Therapeutics Inc. RecoveryEarnings Growth Report & Weekly Watchlist for Consistent Profits - beatles.ru
Can Cartesian Therapeutics Inc. rally from current levelsQuarterly Growth Report & High Accuracy Investment Entry Signals - Newser
Detecting price anomalies in Cartesian Therapeutics Inc. with AI2025 Investor Takeaways & Daily Technical Stock Forecast Reports - Newser
Strategies to average down on Cartesian Therapeutics Inc.Market Growth Report & Risk Managed Investment Entry Signals - Newser
Is Cartesian Therapeutics Inc. stock bottoming outJuly 2025 Trends & Target Return Focused Stock Picks - Newser
Cartesian Therapeutics Inc. stock outlook for YEARCPI Data & Free Daily Entry Point Trade Alerts - Newser
Will Cartesian Therapeutics Inc. bounce back from current supportPrice Action & Weekly High Return Forecasts - Newser
Order flow analysis tools used on Cartesian Therapeutics Inc.Quarterly Portfolio Review & Free Low Drawdown Momentum Trade Ideas - Newser
Using economic indicators to assess Cartesian Therapeutics Inc. potentialWeekly Trade Analysis & High Accuracy Investment Entry Signals - Newser
What’s Cartesian Therapeutics Inc.’s historical returnInflation Watch & Fast Moving Market Watchlists - khodrobank.com
Can Cartesian Therapeutics Inc. maintain sales growthMarket Activity Recap & Stepwise Entry/Exit Trade Alerts - khodrobank.com
Is Cartesian Therapeutics Inc. a potential multi bagger2025 EndofYear Setup & Growth Focused Investment Plans - خودرو بانک
Is Cartesian Therapeutics Inc. reversing from oversold territory2025 Risk Factors & Daily Stock Trend Watchlist - Newser
FOMO Trade: Should value investors consider Cartesian Therapeutics Inc.Portfolio Update Summary & Real-Time Volume Analysis Alerts - khodrobank.com
Is Cartesian Therapeutics Inc. a defensive stockWeekly Trade Recap & Weekly High Momentum Picks - khodrobank.com
Is Cartesian Therapeutics Inc. showing signs of accumulationTrade Exit Summary & Free Safe Entry Trade Signal Reports - Newser
Will Cartesian Therapeutics Inc. stock hit new highs in YEARJuly 2025 Gainers & Reliable Entry Point Trade Alerts - khodrobank.com
Predicting Cartesian Therapeutics Inc. trend using moving averagesQuarterly Profit Review & Consistent Income Trade Ideas - Newser
Can swing trading help recover from Cartesian Therapeutics Inc. lossesJuly 2025 Selloffs & Fast Momentum Stock Entry Tips - Newser
What are analysts’ price targets for Cartesian Therapeutics Inc.2025 Retail Activity & Free Reliable Trade Execution Plans - khodrobank.com
Is Cartesian Therapeutics Inc. in a long term uptrendMarket Performance Summary & Weekly High Conviction Trade Ideas - khodrobank.com
Sector ETF performance correlation with Cartesian Therapeutics Inc.July 2025 Fed Impact & AI Driven Price Forecasts - Newser
How institutional ownership impacts Cartesian Therapeutics Inc. stockDividend Hike & Risk Controlled Daily Trade Plans - Newser
Will Cartesian Therapeutics Inc. Sustain Its Chart Breakout getLinesFromResByArray error: size == 0 - kangso.co.kr
News impact scoring models applied to Cartesian Therapeutics Inc.July 2025 Big Picture & Safe Entry Point Identification - Newser
Can volume confirm reversal in Cartesian Therapeutics Inc.Portfolio Risk Summary & Accurate Buy Signal Alerts - Newser
What momentum shifts mean for Cartesian Therapeutics Inc.2025 Stock Rankings & Reliable Trade Execution Plans - Newser
Cartesian Therapeutics Inc. Sees Spike in Bullish Option Flow2025 Pullback Review & Free Daily Entry Point Trade Alerts - beatles.ru
What technical models suggest about Cartesian Therapeutics Inc.’s comebackQuarterly Market Summary & Reliable Price Action Trade Plans - Newser
How to use a screener to detect Cartesian Therapeutics Inc. breakoutsExit Point & Fast Gaining Stock Strategy Reports - Newser
Chart overlay techniques for tracking Cartesian Therapeutics Inc.Market Movement Recap & Consistent Profit Trade Alerts - Newser
Will Cartesian Therapeutics Inc. stock recover after recent drop2025 Institutional Moves & Long Hold Capital Preservation Plans - Newser
Finanzdaten der Cartesian Therapeutics Inc-Aktie (RNAC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cartesian Therapeutics Inc-Aktie (RNAC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| English Emily | Chief Operations Officer |
Apr 15 '25 |
Option Exercise |
3.30 |
7,500 |
24,750 |
47,726 |
| SPRINGER TIMOTHY A | Director |
Apr 10 '25 |
Buy |
10.47 |
48,595 |
508,751 |
620,175 |
| SPRINGER TIMOTHY A | Director |
Apr 09 '25 |
Buy |
9.43 |
41,782 |
393,947 |
571,580 |
| SPRINGER TIMOTHY A | Director |
Apr 11 '25 |
Buy |
10.77 |
36,338 |
391,455 |
656,513 |
| SPRINGER TIMOTHY A | Director |
Apr 10 '25 |
Buy |
10.47 |
8,575 |
89,773 |
8,637,273 |
| SPRINGER TIMOTHY A | Director |
Apr 09 '25 |
Buy |
9.43 |
7,373 |
69,517 |
8,628,698 |
| SPRINGER TIMOTHY A | Director |
Apr 11 '25 |
Buy |
10.77 |
6,412 |
69,074 |
8,643,685 |
| SPRINGER TIMOTHY A | Director |
Mar 20 '25 |
Buy |
15.59 |
54,889 |
855,593 |
8,621,325 |
| SPRINGER TIMOTHY A | Director |
Mar 19 '25 |
Buy |
14.97 |
20,234 |
302,962 |
8,566,436 |
| SPRINGER TIMOTHY A | Director |
Mar 18 '25 |
Buy |
14.42 |
14,740 |
212,599 |
8,546,202 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):